- Financial district in Tokyo, Japan
The shares of Daiichi Sankyo are traded on the Tokyo Stock Exchange (TSE), Osaka Stock Exchange (OSE) and Nagoya Stock Exchange (NSE). The shares are not traded on European stock exchanges at this time.
As a result, the Daiichi Sankyo Investor Relations Department in Tokyo is responsible for shareholder relations and support. All financial information and reports are provided by the company’s headquarters.
Nearly half of the shares are held by financial institutions. More than 70 per cent are held in Japan. As of 31 March 2012, the company had 114,396 shareholders. more...
The Daiichi Sankyo Group is one of the world's 20 leading global pharmaceutical companies.
By 2015, the company wants to achieve recognition as a "Global Pharma Innovator". more...
In fiscal year 2011, Daiichi Sankyo increased its net sales from €8.55 billion to €8.62 billion. Operating income fall to €901.3 million. These results were achieved by about 32,000 employees worldwide. Daiichi Sankyo is a public-listed company with more than 114,396 shareholders. About 30 per cent of our shareholders come from outside Japan. more...